BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9613787)

  • 1. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
    Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
    Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive stem cell selection--basic science.
    Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
    Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient isolation of human CD34 positive hemopoietic progenitor cells by immune panninga.
    Holyoake TL; Alcorn MJ; Richmond LJ; Freshney MG; Pearson C; Fitzsimons E; Steward WP; Dunlop DJ; Pragnell IB
    Stem Cells; 1994 Jan; 12(1):114-24. PubMed ID: 7511456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
    Chang Q; Harvey K; Akard L; Thompson J; Dugan MJ; English D; Jansen J
    Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.
    Almici C; Carlo-Stella C; Mangoni L; Garau D; Cottafavi L; Ventura A; Armanetti M; Wagner JE; Rizzoli V
    Stem Cells; 1995 Sep; 13(5):533-40. PubMed ID: 8528103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors.
    Koller MR; Manchel I; Brott DA; Palsson Bø
    Exp Hematol; 1996 Nov; 24(13):1484-93. PubMed ID: 8950231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection.
    Winslow JM; Liesveld JL; Ryan DH; Dipersio JF; Abboud CN
    Bone Marrow Transplant; 1994 Aug; 14(2):265-71. PubMed ID: 7527686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large scale recovery and characterization of stromal cell-associated primitive haemopoietic progenitor cells from filter-retained human bone marrow.
    Blazsek I; Delmas Marsalet B; Legras S; Marion S; Machover D; Misset JL
    Bone Marrow Transplant; 1999 Apr; 23(7):647-57. PubMed ID: 10218840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of progenitor cell function in CD34+ cells purified using a novel O-sialoglycoprotease.
    Marsh JC; Sutherland DR; Davidson J; Mellors A; Keating A
    Leukemia; 1992 Sep; 6(9):926-34. PubMed ID: 1381456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fractionation procedure of mouse bone marrow cells yielding exclusively pluripotent stem cells and committed progenitors.
    Bauman JG; Wagemaker G; Visser JW
    J Cell Physiol; 1986 Jul; 128(1):133-42. PubMed ID: 2424920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and morphological characterization of immunomagnetically selected CD34+ hematopoietic progenitor cells.
    Servida F; Soligo D; Caneva L; Bertolini F; de Harven E; Campiglio S; Corsini C; Deliliers GL
    Stem Cells; 1996 Jul; 14(4):430-8. PubMed ID: 8843544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
    Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.
    de Wynter EA; Coutinho LH; Pei X; Marsh JC; Hows J; Luft T; Testa NG
    Stem Cells; 1995 Sep; 13(5):524-32. PubMed ID: 8528102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.